2 not yet recruiting, 2 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Alcohol-Associated Hepatitis: new trials by email Literature Review of Alcohol-Associated Hepatitis trials Research Report on Alcohol-Associated Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease PEth Based Contingency Management, PEth Monitoring with Fixed Incentives - Alcohol Use Disorder, Alcohol-associated Liver Disease | Not applicable | Not yet recruiting | Massachusetts General Hospital | 90 | 2026-08-01 | 2026-03-12 |
| Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial IL-22, Prednisone, Acamprosate - Alcohol-associated Hepatitis | Phase 2 | Recruiting | Samer Gawrieh | 216 | 2026-01-27 | 2026-07-15 |
| Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis bacteriophage preparation, Bacteriophage preparation - Alcohol-Associated Hepatitis | Phase 1 | Not yet recruiting | Nterica Bio inc | 12 | 2025-11-05 | 2025-08-17 |
| Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis Alfa1 Antitrypsin - Alcohol-Associated Hepatitis | Phase 2 | Recruiting | Medical University Innsbruck | 16 | 2025-06-18 | 2026-10-09 |
Alcohol Abstinence (1) · Alcoholism (1) · Liver Cirrhosis, Alcoholic (1) · Liver Diseases (1)
Alcohol-Induced Disorders (1) · Alcohol-Related Disorders (1) · Behavior (1) · Chemically-Induced Disorders (1) · Digestive System Diseases (1) · Drinking Behavior (1) · Fibrosis (1) · Liver Cirrhosis (1) · Liver Diseases, Alcoholic (1) · Mental Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Substance-Related Disorders (1)
Acamprosate (1) · Behavior Therapy (1) · Ethanol (1) · Interleukin-22 (1) · Motivational Interviewing (1) · Prednisone (1) · alpha 1-Antitrypsin (1) · eflepedocokin alfa (1)
Massachusetts General Hospital (1) · Medical University Innsbruck (1) · Nterica Bio inc (1) · Samer Gawrieh (1)
United States (2) · Austria (1)
R34AA032300 (1), U24AA026969 (1)